Study guide

3.2 Subjective Global Assessment (7-Point SGA) in Dialysis

Board Certified Specialist in Renal Nutrition CSR

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview & Kidney Disease Foundations

1.1 CDR CSR Exam Structure, Eligibility, Logistics & the 2023 Content Outline 1.2 Renal Anatomy, Physiology & Glomerular Hemodynamics 1.3 CKD Etiology, KDIGO Staging & Progression Risk

2 Chapter 2: Domain 1 — Anthropometric & Body Composition Assessment

2.1 Dry Weight Determination, Fluid Assessment & Interdialytic Weight Gain 2.2 Anthropometric Measurement Standards (Knee Height, Skinfolds, Frame Size) 2.3 Body Composition Analysis: BIA, BIS, DXA & Handgrip Dynamometry

3 Chapter 3: Domain 1 — Nutrition-Focused Physical Findings & PEW Assessment Tools

3.1 Protein-Energy Wasting (PEW) Diagnostic Criteria & Pathophysiology 3.2 Subjective Global Assessment (7-Point SGA) in Dialysis 3.3 Malnutrition Inflammation Score (MIS) & Scoring Protocols 3.4 Nutrition-Focused Physical Exam (NFPE) for Muscle & Fat Loss

4 Chapter 4: Domain 1 — Diet, Medical, Medication & Psychosocial History

4.1 Dietary Intake Assessment & Food Frequency Methods in CKD 4.2 Medical & Medication History: Drug–Nutrient Interactions and Supplements 4.3 Psychosocial, Social & Functional History in Renal Nutrition Assessment

5 Chapter 5: Domain 1 — Medical Tests & Procedures by Treatment Modality

5.1 Hemodialysis Clinical Assessment & Vascular Access Considerations 5.2 Peritoneal Dialysis & Peritoneal Glucose Absorption Assessment 5.3 AKI, CRRT & Pediatric Renal Disease Assessment

6 Chapter 6: Domain 1 — Nutrition Diagnosis: Terminology, Etiology & Reasoning

6.1 Standardized Nutrition Diagnostic Terminology (NCP) in Nephrology 6.2 Etiology & Root-Cause Analysis for Renal Nutrition Problems 6.3 Diagnostic Reasoning for Fluid, Mineral & Protein Imbalances

7 Chapter 7: Domain 1 — Nutrition Diagnosis in Complex Patients

7.1 Formulating Valid PES Statements in Complex Dialysis Patients 7.2 Differentiating PEW, Sarcopenia & Cachexia in CKD 7.3 Diagnostic Prioritization across Cardiorenal & Diabetic Nephropathy

8 Chapter 8: Domain 2 — Food & Nutrient Delivery: Protein & Energy

8.1 KDOQI 2020 Protein Targets: Non-Dialysis CKD (LPD vs. VLPD) 8.2 Protein Prescriptions for Hemodialysis and Peritoneal Dialysis 8.3 Energy Requirements, Carbohydrates & Plant-Dominant Diets (PLADO)

9 Chapter 9: Domain 2 — Electrolytes, Fluid, Acid–Base & Micronutrients

9.1 Potassium Management: Dietary Restriction, Leaching & K-Binders 9.2 Sodium & Fluid Prescriptions across Dialysis Modalities 9.3 Acid-Base Homeostasis & Bicarbonate Replacement Therapy 9.4 Micronutrient, Trace Mineral & Vitamin Supplementation in ESRD

10 Chapter 10: Domain 2 — Medications & Specialized Nutrition Support

10.1 CKD-MBD Pharmacology: Phosphorus Binders, Vitamin D & Calcimimetics 10.2 Anemia Management: Iron Homeostasis, IV Iron Protocols & ESAs 10.3 Enteral, IDPN & Intraperitoneal Amino Acid Nutrition Support

11 Chapter 11: Domain 2 — Treatments Across the Continuum: Transplant & Comorbidities

11.1 Kidney Transplant I: Candidacy, Living Donors & the Early Post-Transplant Period 11.2 Kidney Transplant II: Long-Term Care, Immunosuppressant Side Effects & Graft Protection 11.3 Diabetes Management Across CKD Stages: Glycemic Targets, Medications & MNT 11.4 GI & Cardiovascular Comorbidities: Gastroparesis, Constipation, Liver Disease, Lipids & Blood Pressure

12 Chapter 12: Domain 2 — Monitoring & Evaluation: Labs, Fluid & Nutrition Trends

12.1 Renal Laboratory Surveillance: Frequency, Target Ranges & Trending 12.2 Monitoring Fluid Balance, Blood Pressure & Cardiovascular Risk 12.3 Longitudinal Assessment of Nutritional Status & Weight Trajectories

13 Chapter 13: Domain 2 — Monitoring Dialysis Adequacy & Kinetics

13.1 Hemodialysis Adequacy: Urea Kinetic Modeling, spKt/V & URR 13.2 Peritoneal Dialysis Adequacy & Peritoneal Equilibration Test (PET) 13.3 Normalized Protein Catabolic Rate (nPCR / nPNA) Interpretation 13.4 Troubleshooting Inadequate Dialysis vs. Dietary Non-Adherence

14 Chapter 14: Domain 2 — Care Coordination, Communication & Education

14.1 Interdisciplinary Team Care, Patient Education & Counseling Ethics 14.2 Individualized & Group Education: Medicare MNT and KDE Benefits, Caregivers & Curricula 14.3 Interfacility Coordination of Care: Hospital Handoffs, Transfers, Transplant Centers & Modality Changes 14.4 Psychosocial Support & Resources: Food Assistance, Financial Programs, Rehabilitation & Peer Support

15 Chapter 15: Domain 3 — Regulations & Quality Management

15.1 CMS Conditions for Coverage: IDT, Dietitian Qualifications, Assessment & Plan-of-Care Timelines 15.2 QAPI Programs, PDSA Cycles & the ESRD Quality Incentive Program 15.3 Medicare ESRD Payment, ESRD Networks, EQRS & the Survey Measures Assessment Tool

16 Chapter 16: Domain 3 — Evidence-Based Practice: Guidelines, Research & Protocols

16.1 The KDOQI 2020 Nutrition in CKD Guideline (NKF–Academy EAL): Grades & Key Statements 16.2 KDIGO & Companion Guidelines: CKD 2024, CKD-MBD, Anemia 2026, Diabetes, BP, Lipids & AKI 16.3 Appraising Current Research: Study Designs, Bias, Statistics & Landmark Renal Trials 16.4 Clinical Protocols & Algorithms: Dietitian-Managed MBD, Anemia, Potassium & Nutrition-Support Pathways

3.2 Subjective Global Assessment (7-Point SGA) in Dialysis

Key Takeaways Explain This Topic AI

The 7-point Subjective Global Assessment (SGA) is a validated, semi-quantitative clinical tool adapted from Detsky's original 3-tier surgical classification for dialysis populations (CANUSA) and endorsed by KDOQI to increase diagnostic sensitivity.

Weight history assessment requires evaluating established post-dialysis dry weight to prevent occult extracellular fluid overload or interdialytic fluid weight gain from masking severe somatic tissue wasting.

The 7-point Likert scale classifies patients into well-nourished (scores 6–7), mild to moderately malnourished (scores 3–5), and severely malnourished (scores 1–2).

Physical examination in SGA assesses subcutaneous fat depletion across three anatomical sites (orbital, triceps/biceps, thoracic) and muscle wasting across both upper and lower body compartments.

Scores ≤ 5 correlate strongly and independently with increased hospitalization rates, prolonged inpatient length of stay, and all-cause cardiovascular and infectious mortality in hemodialysis and peritoneal dialysis.

Last updated: September 2026

Subjective Global Assessment (7-Point SGA) in Dialysis

Core Clinical Principle: The 7-Point Subjective Global Assessment (SGA) is the bedside tool that KDOQI 2020 recommends as valid and reliable for assessing nutritional status in adults on dialysis (statement 1.5.1, grade 1B). Unlike static laboratory markers that fluctuate with systemic inflammation, the 7-point SGA integrates longitudinal medical history with hands-on physical examination to deliver a highly predictive, semi-quantitative measure of somatic protein and energy stores.

Originally developed by Detsky and colleagues (1987) for general surgical patients, the original SGA classified individuals into three broad categories: Class A (Well-nourished), Class B (Moderately malnourished), and Class C (Severely malnourished). While effective in acute surgical triage, this 3-tier system lacked the granularity needed to detect subtle nutritional shifts, early catabolic declines, or gradual improvements resulting from targeted medical nutrition therapy in chronic kidney disease.

To address this limitation, the CANUSA Peritoneal Dialysis Study Group and KDOQI adapted the instrument into a 7-point Likert scale (where 1 indicates the most severe malnutrition and 7 represents a robustly well-nourished state). This 7-point continuum provides exceptional clinical sensitivity for tracking longitudinal nutritional trajectories in both maintenance hemodialysis (HD) and peritoneal dialysis (PD) populations.

1. Medical & Weight History Components

The medical history component of the 7-point SGA evaluates five distinct domains, capturing the chronicity and metabolic severity of nutritional insult:

A. Weight Change and Trajectory

Weight history must be interpreted with extreme clinical rigor in dialysis:

Assessment of Post-Dialysis Dry Weight: Dietitians must evaluate changes in prescribed dry weight (post-hemodialysis weight or empty-abdomen weight in PD) rather than pre-dialysis weights. Interdialytic weight gains (IDWG) from fluid retention or occult volume expansion can completely mask severe underlying muscle and fat loss.

Six-Month Net Change: Net percentage loss over the preceding 6 months is calculated: [(Usual Dry Weight - Current Dry Weight) / Usual Dry Weight] * 100 . Loss < 5% is considered minor; 5% to 10% is moderate; > 10% is severe.

Acute Two-Week Trajectory: The clinician determines the directional momentum of weight over the past 2 weeks: actively continuing to lose , stabilized , or actively gaining . A patient who lost 8% over 6 months but has gained 1.5 kg of true somatic weight over the past 2 weeks receives a higher (improved) SGA score than one continuing to lose weight acutely.

B. Dietary Intake Changes

The patient's habitual dietary intake is categorized by duration and degree of deficit:

Normal Habitual Diet: Adequate caloric and protein intake meeting KDOQI guidelines.

Subnormal Solid Diet: Mild reduction in quantity or meal frequency (e.g., leaving 25–50% of food on the plate; missing 1 meal daily).

Full Liquid Diet: Inability to tolerate solid foods, relying on oral nutrition supplement beverages or soups.

Hypocaloric Clear Liquid: Markedly inadequate intake consisting of broths, tea, or water.

Near-Complete Starvation / Fasting: Minimal to zero oral intake for multiple days.

C. Gastrointestinal Symptoms

Persistent gastrointestinal distress is a major driver of uremic anorexia and PEW. To receive diagnostic weight in the SGA, symptoms must occur almost daily for at least 2 consecutive weeks :

Anorexia: Persistent loss of appetite, often accompanied by uremic dysgeusia (metallic taste) or meat aversion.

Nausea: Constant or postprandial nausea interfering with intake.

Vomiting: Frequency of emesis (occasional vs. daily post-dialysis emesis).

Diarrhea: Chronic loose stools leading to nutrient malabsorption and electrolyte wasting.

Early Satiety / Abdominal Fullness: Particularly prevalent in peritoneal dialysis patients due to increased intra-abdominal pressure from dialysate dwell volumes.

D. Functional Capacity / Energy Level

Functional status reflects the systemic impact of muscle wasting and chronic fatigue:

Normal Functional Capacity: Ambulatory, fully independent in activities of daily living (ADLs), able to perform occupational work or vigorous exercise.

Subnormal Work Performance: Ambulatory and independent in ADLs, but struggles with heavy exertion, stair climbing, or employment duties.

Ambulatory with Limited ADLs: Difficulty with basic self-care, frequent resting, spending > 50% of waking hours seated.

Wheelchair-Bound or Bedridden: Complete physical dependency, severe muscle weakness, inability to ambulate independently.

E. Metabolic Stress and Comorbid Illness

Catabolic stress accelerates somatic proteolysis. The clinician assesses the severity of underlying medical stressors:

Low Stress: Stable maintenance dialysis, controlled hypertension, absence of acute infection.

Moderate Stress: Controlled diabetes mellitus, congestive heart failure (NYHA Class II), chronic vascular access complications, mild localized decubitus ulcer.

Severe Catabolic Stress: Active infectious peritonitis in PD, vascular access bacteremia/sepsis, active inflammatory bowel disease, systemic vasculitis, major surgery within 30 days, or non-healing diabetic gangrenous ulcers.

2. Physical Examination Components

The physical examination objectively verifies the historical data by evaluating somatic fat and muscle stores alongside fluid volume:

Detailed Physical Examination Matrix

Examination Domain Anatomical Sites Evaluated Normal (Well-Nourished) Moderate Loss (Score 3–5) Severe Loss (Score 1–2)

Subcutaneous Fat Loss • Orbital fat pads (under eyes); Triceps and biceps skinfolds; Thoracic cage and mid-axillary ribs Full, rounded cushions below lower eyelids; generous skinfold pinch (> 1.0 cm); ribs padded with smooth subcutaneous layer Slight dark hollows under eyes; reduced upper-arm pinch thickness (0.5–0.9 cm); ribs visibly outlined but palpable fat present Deep hollow, sunken eyes with prominent orbital rims; paper-thin pinch (< 0.5 cm); skin stretched tightly over prominent bare ribs

Muscle Wasting • Temporalis muscles (temples); Clavicle & deltoid muscles; Scapula and spine; Dorsal interosseous (hands); Quadriceps & patella; Gastrocnemius (calves) Convex or flat temples during jaw clench; clavicles covered with deltoid padding; rounded shoulders; prominent dorsal hand muscle bulge; firm, bulky thighs and calves Slight temple indentation; clavicles visible but not sharp; acromion process slightly rounded; slight dorsal hand depression; mild knee prominence with reduced quadriceps tone Severe scooped temple hollows; sharply protruding "coat-hanger" clavicles; squared shoulders (bony acromion); deep dorsal hand concavity; protruding kneecaps with hollows; flat, flaccid calves

Fluid Status & Edema • Ankle and pretibial region; Presacral area (recumbent); Ascites (abdominal distension) No peripheral pitting edema; absent presacral edema; non-distended abdomen 1+ to 2+ pitting edema (mild to moderate indentation resolving in < 15 seconds); mild dependent ankle swelling 3+ to 4+ pitting edema (deep indentation lasting > 1 minute); marked distortion of lower extremities, presacral edema, or ascites

3. The 7-Point Scoring Classification & Clinical Rubric

After synthesizing all historical domains and physical examination findings, the clinician assigns an aggregate clinical score from 1 to 7 based on holistic clinical judgment: 7-POINT SGA SPECTRUM

  • [ 1 -------- 2 ] [ 3 -------- 4 -------- 5 ] [ 6 -------- 7 ]
  • Severely Malnourished Mild to Moderately Malnourished Well-Nourished
  • Severe >10% weight loss • 5-10% weight loss; subnormal diet • Stable dry weight
  • Profound muscle hollows • Mild/moderate wasting at 1-2 sites • Normal muscle/fat bulk
  • Paper-thin fat pinch • Reduced skinfold thickness • High functional capacity
  • Bedridden / severe GI • Moderate functional impairment • No persistent GI symptoms
  • Clinical Tiers and Scoring Definitions
  • Scores 6–7: Well-Nourished

Score 7: Patient demonstrates robust nutritional health. Stable dry weight (or intentional, healthy gain); no dietary restrictions beyond standard renal guidelines; zero persistent GI symptoms; high functional capacity; full, well-developed muscle bulk and normal subcutaneous fat cushions.

Score 6: Mostly well-nourished with very minor, vague symptoms (e.g., slight transient decrease in appetite over 1 week, or very subtle, questionable loss of upper-arm fat), but overall somatic stores, weight, and function remain entirely preserved.

Scores 3–5: Mild to Moderately Malnourished

Score 5: Mild nutritional decline. Minor weight loss (< 5% over 6 months); slight reduction in solid dietary intake; mild fatigue; minimal loss of subcutaneous fat or slight loosening of skin over the triceps, with well-preserved muscle mass.

Score 4: Definitive, unequivocal moderate malnutrition. Moderate weight loss (5% to 10% over 6 months); subnormal solid intake for several weeks; daily mild-to-moderate GI symptoms (nausea, early satiety); moderate muscle wasting (mild temporal hollowing, prominent clavicle) and obvious subcutaneous fat depletion; noticeable reduction in physical endurance.

Score 3: On the threshold of severe malnutrition. Weight loss approaching 10%; substantial dietary restriction; moderate-to-severe muscle wasting across multiple anatomical beds; ambulatory but struggling with basic household ADLs.

Scores 1–2: Severely Malnourished

Score 2: Advanced, profound nutritional depletion. Severe involuntary weight loss (> 10% over 6 months); persistent liquid diet or starvation; daily vomiting or intractable diarrhea; widespread muscle wasting (deep scooped temples, squared shoulders, visible ribs, interosseous depressions); severe fat loss (< 0.5 cm triceps pinch); marked functional impairment.

Score 1: Terminal, extreme cachexia. Total somatic muscle and fat exhaustion; completely bedridden; intractable uremic anorexia; skin tightly stretched across skeletal framework. Highest acute mortality risk.

4. Prognostic Validity and Longitudinal Monitoring

Extensive multicenter validation studies, including data from the CANUSA study and the Dialysis Outcomes and Practice Patterns Study (DOPPS) , have firmly established the prognostic power of the 7-point SGA:

Mortality Prediction: In the CANUSA peritoneal dialysis cohort, each 1-point higher SGA score was associated with about a 25% lower relative risk of death ; lower scores consistently predict higher mortality in HD and PD.

Hospitalization Risk: Patients scoring in the malnourished range (SGA ≤ 5) have higher hospitalization rates and longer lengths of stay than well-nourished peers (scores 6–7).

Longitudinal Tracking: Because the 7-point scale detects single-point increments, it is an ideal metric for quality assessment and performance improvement (QAPI) surveillance. KDOQI 2020 suggests nutrition screening at least biannually and a comprehensive assessment within the first 90 days of dialysis and annually (OPINION); in practice, many programs repeat the 7-point SGA about every 6 months in stable dialysis patients , and monthly in patients scoring ≤ 5 to monitor response to oral nutritional supplements (ONS), intradialytic parenteral nutrition (IDPN), or intraperitoneal amino acids (IPAA).

Loading diagram... 7-Point SGA Clinical Workflow and Scoring Architecture